The previous page is sending you to https://www.businesswire.com/news/home/20210621005867/en/ViiV-Healthcare-and-Halozyme-enter-global-collaboration-and-license-agreement-for-ENHANZE%C2%AE-drug-delivery-technology-to-enable-development-of-%E2%80%9Cultra-long-acting%E2%80%9D-medicines-for-HIV.

 If you do not want to visit that page, you can return to the previous page.